Merck Patent Gmbh

Yuhan Corporation

Eunjeong Jeong

June Hyung Lee

Ju Young Park

Ki Hong Kim

Jong-Seo Lee

Moo Young Song

JiHoon Kim

Durairaj Baskaran

Eun-Jung Lee

Byung Hyun Choi

Na Rae Lee

Young Bong Park

Bong-Kook Ko

Kyu-Tae Kim

Kwang-Hoon Lee

Nakho Chang

Sunghyun Choi

The disclosed subject matter relates compounds of structure (I), and polymers of structure (II) having a polydispersity ranging from 1 to about 1.1, compositions comprising said polymers and a spin casting solvent, the process of forming a pinning layer selectively on metal with said composition and the process of using said pinning layers to affect chemoepitaxy directed self-assembly of an overlying block copolymer, and the subsequent process of pattern transfer of this self-assembled layer into a substrate by etching.

Brush polymer terminated with phosphonate for DSA

Disclosed are a novel antibody specifically binding to the tumor-immunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain) or an antigen-binding fragment thereof, a nucleic acid encoding the antibody or the antigen-binding fragment thereof, a vector and a host cell including the nucleic acid, a method for producing the antibody or the antigen-binding fragment thereof, a pharmaceutical composition containing the antibody or the antigen-binding fragment thereof as an active ingredient, and uses of the pharmaceutical composition. The antibody specifically binding to TIGIT or the antigen-binding fragment thereof and the pharmaceutical composition containing the same as an active ingredient are preferably used for the treatment of cancer or tumors.

Anti-TIGIT antibodies and uses thereof

Growing community of inventors

Gyeonggi-do, South Korea

Eunjeong Jeong